Abdukahal, Diana A.
HRN: 23-58-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2023
AMPICILLIN 1GM (VIAL)
08/22/2023
08/28/2023
IV
250mg
Q8h
Meningitis
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes